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Abstract
Background: Fibroblast growth factors (FGFs) are multifunctional proteins that play important
roles in cell communication, proliferation and differentiation. However, many aspects of their
activities are not well defined. LET-756, one of the two C. elegans FGFs, is expressed throughout
development and is essential for worm development. It is both expressed in the nucleus and
secreted.
Results: To identify nuclear factors associated with LET-756, we used three approaches. First, we
screened a two-hybrid cDNA library derived from mixed stages worms and from a normalized
library, using LET-756 as bait. This direct approach allowed the identification of several binding
partners that play various roles in the nucleus/nucleolus, such as PAL-1, a transcription regulator,
or RPS-16, a component of the small ribosomal subunit. The interactions were validated by co-
immunoprecipitation and determination of their site of occurrence in mammalian cells. Second,
because patterns of protein interactions may be conserved throughout species, we searched for
orthologs of known mammalian interactors and measured binary interaction with these predicted
candidates. We found KIN-3 and KIN-10, the orthologs of CK2α and CK2β, as new partners of
LET-756. Third, following the assumption that recognition motifs mediating protein interaction may
be conserved between species, we screened a two-hybrid cDNA human library using LET-756 as
bait. Among the few FGF partners detected was 14-3-3β. In support of this interaction we showed
that the two 14-3-3β orthologous proteins, FTT-1 and FTT-2/PAR-5, interacted with LET-756.
Conclusion: We have conducted the first extensive search for LET-756 interactors using a multi-
directional approach and established the first interaction map of LET-756/FGF with other FGF
binding proteins from other species. The interactors identified play various roles in developmental
process or basic biochemical events such as ribosome biogenesis.
Background
FGFs constitute a superfamily of pleiotropic growth fac-
tors involved in multiple cellular processes such as
mitogenesis, angiogenesis and mesoderm induction [1].
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There are 22 FGFs in humans. Except FGF11-14, they exert
their biological activities by acting as extracellular growth
factors binding to receptors (FGFR1-4) of the tyrosine
kinase receptor superfamily [2]. In addition, FGF1-3 and
FGF11-14 are localized in the nucleus and function intra-
cellularly [3]. Intracellular FGFs bind to several proteins
that play a role in FGF trafficking: FIBP, which allows
FGF1 to shuttle between the cytosol and the nucleus [4],
synaptotagmin-1, which allows FGF1 exocytosis [5],
Cystein Rich FGF receptor (CFR), which forms complexes
with various FGFs and allows their secretion [6,7], and
LRP-1 and 2 (lipoprotein receptor-related proteins),
which in conjunction with DAB-1 (Disabled) regulate
EGL-17/FGF export in C. elegans [8]. FGF interactors may
also regulate FGF nuclear activity; this is the case of Casein
Kinase II regulatory subunits [9] and splicing factor
SF3a66 [10], which both interact with FGF2. Finally, pro-
teins of the extracellular matrix such as fibstatin and
fibrinogen interact with FGF2 [11,12].
LET-756 is one of the two FGFs of C. elegans [13, 14 for
reviews]. It is essential for worm development [15]. Like
some mammalian FGFs, it acts both intra and extracellu-
larly. The molecular motif allowing secretion [16] and
some of LET-756 extracellular functions have been
described [17,18] but the intracellular functions remain
poorly defined, although nuclear localization is probably
of importance [19]. To further characterize the functions
of LET-756, we used yeast two-hybrid screens to identify
proteins that interact with this FGF. We identified several
interacting proteins involved in various developmental
processes or in basic biochemical events such as ribosome
biogenesis, and validated some of the interactions by co-
immunoprecipitation and/or colocalization.
Results
Identification of nematode LET-756 binding proteins by 
yeast two-hybrid library screens
To identify worm proteins that interact with LET-756, we
used the two-hybrid system in the MAV103 yeast with
LET-756 fused to the Gal-4 DNA binding domain (pDB)
as bait and two C. elegans libraries. The latter were either
normalized [20] to contain one representative of each
expressed gene of the whole genome (ORFeome) or
derived from a mixed stage worm population. Library
clones were coupled to the Gal-4 activating domain
(pAD). The bait did not show any intrinsic transcriptional
activation of the three yeast reporter genes. In a screen of
approximately 4 × 106 transformants, 41 clones were pos-
itive for the two reporters tested, or for only one reporter
but with great intensity. The gap repair technique con-
firmed 9 clones (Table 1). Sequencing of these clones and
blastn or tblastx interrogation of databases revealed uni-
dentified sequences (UIS) and sequences coding for pro-
teins with known functions: UMP synthase, an enzyme
involved in de novo nucleic acid synthesis, cathepsin
(aspartic peptidase A1, pepsinogen family member), RPS-
16 (small ribosomal subunit), transcription factor PAL-1
involved in the anterior-posterior development of the
male [21], DAF-21, a chaperone of the HSP-90 family,
involved in chemosensory transduction and insulin sig-
nalization [22,23], COL-129, an isoform of collagen, and
SKR-2 (homolog of skp1 of S. cerevisiae), a component of
the skp1p/cullin/F-box SCF complex with ubiquitin ligase
activity [24,25]. The latter also shows similarities with
P19, which is associated with cyclinA/CDK2 complex in
humans.
To confirm the results on some on the interactors we
judged potentially relevant, pAD interactor clones were
picked individually from the ORFeome library and tested
directly in yeast two-hybrid system against pDB LET-756.
PAL-1 interacted strongly with LET-756 (two positive
tests). For the other interactors, only one test was clearly
positive (Table 2A).
Identification of LET-756-binding proteins among 
orthologs of known mammalian FGF interactors
The conservation of signaling pathways between worms
and mammals, as well as the conserved FGF structures in
different species [26,27], suggested that orthologs of
human FGF-binding proteins could interact with LET-
756. We used blast interrogation to determine the most
conserved orthologs supposed to retain the ancestral func-
tion of the known human FGF-interactors. These
orthologs were recovered from the ORFeome library and
tested in binary interactions (Table 2B). We found kin-10
(CK2β) and rpl-6 positive for two reporter genes, and kin-
3 (CK2α), hsp-6 (mortalin), F14E5.2 (cystein rich FGF
receptor, CFR) and C18A3.3 (NoBP) positive for one
reporter gene.
Identification of human LET-756-binding proteins
We based our third approach on the assumption that pro-
tein interaction motifs may be conserved between species.
We made a heterologous screen using a cDNA human
library as prey and LET-756 as bait. The yeast two-hybrid
system was used with LET-756 fused to LexA DNA binding
domain as bait (pDB) for the screening of a human pla-
centa cDNA library containing the Gal-4 activating
domain (pAD). Table 3 indicates the number of times the
interactors were isolated and the strength of the interac-
tion. Identified partners were different from those
unveiled by the C. elegans screens but showed similar bio-
logic activities (Table 4). MBD1 and ZN420 are transcrip-
tion factors, 14-3-3β (YWHAB, tyrosine 3-
monooxygenase/tryptophan 5-monooxygenase activa-
tion protein, β polypeptide) has chaperone activity, and
FBLI1 (Filamin-binding LIM protein 1) is a protein of the
Zyxin family.
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Finally, the orthologs of human 14-3-3β , ftt-1/par-5 and
ftt-2, and the orthologs of FBL1, zyx-1a and zyx-1b, were
obtained from the nematode ORFeome library and tested
for direct interaction in yeast two-hybrid system. Table 2C
indicates that FTT-1 and FTT-2, but not ZYX-1a or ZYX-1b,
reacted with the LET-756 bait.
Confirmation of interactions by co- immunoprecipitation 
experiments
A number of interactors we identified have been described
as false positives in various studies. It is the case for HSP
family members and ribosomal proteins, and to some
extent for collagen-related proteins, Zn finger proteins
and proteasome subunits [28]. To validate the interaction
of LET-756 with the candidate partners, co-immunopre-
cipitation experiments were done in Cos-1 cells. Cos-1
Table 2: Direct interactions between LET-756 (DB) and clones derived from the ORFeome library. A) clones detected in the screening 
of the C. elegans libraries; B) orthologs of clones detected in the screening of the human placenta library; C) orthologs of known 
mammalian FGF interactors.
Interactors (AD) LET-756 (DB)
LacZ 3-AT URA
A RPS-16 +/- ++ -
PAL-1 ++ + -
DAF-21 - +* -
COL-129 +/- + -
SKR-2 +/- +/- -
C15C6.2 +/- + -
B KIN-10 (CSNK2B, CK2β) +/- + -
KIN-3 (CSNK2A, CK2α) - + -
HSP-6 (HSPA9B, mortalin) - + -
F14E5.2 (GLG1, CFR) - +/- -
C18A3.3 (EBNA1BP2, NoBP) - +/- -
RPL-6 (RPL6) +/- + -
C FTT-1/PAR-5 (YWHAB, 14-3-3β) +/- + -
FTT-2 (YWHAB, 14-3-3β) +/- + -
ZYX-1a, ZYX-1b (ZN420) - - -
*: 3-AT concentration allowing yeast growth was 20mM except for DAF-21 where it was 40 mM
Table 1: LET-756-interacting proteins identified by screening Y2H C. elegans libraries. Bait used was DB-LET-756. Sequences of AD-
interactor clones are in (58). Clones were assigned scores for LacZ expression, growth on plates lacking histidine but containing 20 or 
40 mM 3-amino triazol (3-AT) and in addition, growth on plates lacking uracil (URA) for the C. elegans libraries
Interactor 
(sequence 
name)
Gene name Human ortholog(s) LacZ 3-AT 20 
mM
3-AT 40 
mM
URA Library
AD-C38D4.6 pal-1 CDX4 (Caudal-type homeobox 
protein 4)
++ + - - cDNA
AD-C47E8.5 daf-21 HSP90 family - ++ + - cDNA
AD-T01C3.6 rps-16 RPS16 (40S ribosomal protein S16) +/- ++ - - cDNA
AD-T07C4.1 - UMPS (UMP-synthase) - +/- - ++ cDNA
AD-C15C8.3 - CTSE (Cathepsin E precursor) +/- + - - cDNA
AD-C15C6.2b C15C6.2 - - + + - cDNA
AD-M18.1 col-129 COL4A5 (Collagen alpha 5(IV) chain 
precursor)
+/- + +/- - cDNA
AD-F35A5.4 - KRTAP10-4 (Keratin-associated 
protein 10-4)
+ - - - AD-ORFeome
AD-F46A9.4 skr-2 SKP1A (S-phase kinase-associated 
protein 1A)
+/- ++ - - AD-ORFeome
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cells were transiently cotransfected with HA-tagged part-
ner constructs and LET-756::GFP, and the lysates were
immunoprecipitated with anti-GFP. Fig. 1 shows the
result of a western blot probed first with anti-HA to reveal
the co-immunoprecipitated proteins, and second with
anti-GFP to normalize the transfection with LET-756. All
tested partners immunoprecipitated with LET-756,
although with different strength, unrelated to their level
of expression (not shown). The 14-3-3β and KIN-10 pro-
teins were reproducibly the less efficient. To make sure
that overexpression of the two tagged proteins was not
responsible for the immunoprecipitation, we used TACC1
as an unrelated HA-tagged control. In similar condition,
TACC1 was unable to immunoprecipitate LET-756.
Confirmation of interactions by subcellular colocalization 
experiments
To further confirm FGF/partner interaction in mamma-
lian cells, HA-tagged partners were co-expressed with LET-
756::GFP in Cos-1 cells and their respective subcellular
localization was examined. As already described [16,19],
LET-756::GFP localized in specific regions of the nucleus
where splicing factors are concentrated. Immunofluores-
cence microscopy using anti-HA antibodies revealed PAL-
1 in foci in the nucleus that colocalized with LET-756 (Fig.
2). We have previously established [19] that treatment of
LET-756 expressing cells with actinomycin D (a drug
inhibiting Pol I and Pol II activities) displaces LET-756 to
the perinucleolar and nucleolar compartments. Addition
of actinomycin D did not move the PAL-1 protein to the
nucleolus as it did for LET-756 but kept both partners in
close association in nucleoplasmic foci. Other partners,
such as RPL-6, were delocalized by transfection of LET-
756. RPL-6 was localized in large foci mainly in the nucle-
oplasm when transfected alone (column I, Fig. 2) but was
most often dispersed through the nucleoplasm and asso-
ciated with LET-756 when cotransfected with the FGF (Fig.
2, column II to IV). FTT-1/PAR-5 and FTT-2 localized pref-
erentially in the cytoplasm when transfected alone, but
observed also in the nucleus when transfected together
with LET-756. In addition, vesicles containing both LET-
756 and FTT-1 or FTT-2 were visible. KIN-3 colocalized
with LET-756 in nuclei and exhibited a strong expression
in cytoplasm whether LET-756 was present or not whereas
KIN-10 present in nucleoplasm of untransfected LET-756
cells moved with LET-756 in the speckles when co-trans-
fected. Upon actinomycin D treatment both LET-756 and
KIN-10 formed enlarged speckles and moved to the nucle-
olus (Fig. 2). This stricking delocalization observed upon
actinomycin D treated KIN-10 co-transfected cells did not
occurred with KIN-3. In other instances, the partner mod-
ified LET-756 localization: RPS-16 concentrated LET-756
in large foci when both proteins were present in the
nucleus (Fig. 2). The protein encoded by C15C6.2 did not
show any gross colocalization (Fig. 2). Finally, COL-129
was localized only at the Golgi apparatus, whether LET-
756 was present or not, and CFR was localized only in the
cytoplasm.
Table 3B: LET-756-interacting proteins identified by screening Y2H human placenta libraries. B: Description of the proteins and 
identification of the C. elegans ortologs.
Protein Description C.elegans orthologs
YWHAB (14-3-3β) protein with chaperone activity implicated in subcellular 
compartmentalization of binding partners
PAR-5 or FTT1, FTT-2
MBD1 negative regulator of transcription, the methyl CpG-Binding Domain none
EIF3S2 initiator of translation (subunit 9) EIF3-B
FBLI1 protein belonging to the Zyxin family, having 3 LIM domains, involved 
in protein-protein interaction (filamin-binding LIM protein-1)
ZYX-1
ZN420 zinc finger protein with a Krab domain none
*: 3-AT concentration allowing yeast growth was 20mM except for DAF-21 where it was 40 mM
Table 3A: LET-756-interacting proteins identified by screening Y2H human placenta libraries. A: Number of times the clone was 
detected during the Y2H library screening and scores for the different reporter genes.
Interactor times LET-756
lacZ His-3 3-AT (20 mM) 3-AT (40 mM)
YWHAB (14-3-3 β) 11 + + - -
MBD1 1 + + - -
EIF3S2 (eiF3) 1 + + - -
FBLP1 1 + + - -
KRAB100 3 + + + +
*: 3-AT concentration allowing yeast growth was 20mM except for DAF-21 where it was 40 mM
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Discussion
Several growth factors are found in the nucleus in addi-
tion to their other localizations. This is the case for LET-
756 but not for EGL-17, the other C. elegans FGF [29]. The
role of LET-756 in the nucleus is not known. To help char-
acterize this role we searched to identify intracellular
binding partners of LET-756. By using different two-
hybrid screens in yeast, we identified several proteins
Table 5: C. elegans orthologous genes of known human FGF interactors.
FGF Interactor C. elegans or human orthologs
FGF1 HSPA9B (Stress-70 protein, mortalin) [39] hsp-6 (C37H5.8)
FGF1 NP_060979.2 (PRO1855, LOC55379, ribosome-binding protein p34, 
RBP34*) [39]
F56A8.3
FGF1 LDL (Low density lipoproteins) [40] -
FGF1 S100A13 (Calcium binding protein S100A13) [41] -
FGF1 SYT1 (Synaptotagmin-1) [5] snt-1 (F31E8.2)
FGF1 FIBP (FGF-1 intracellular binding protein) [4] -
FGF1 and FGF2 FGFBP1 (Fibroblast growth factor binding protein 1) [42] -
FGF1 and FGF2 CSNK2A (Casein Kinase II, catalytic subunit α) [43] kin-3 (B0205.7)
FGF2 CSNK2B (Casein Kinase II, regulatory subunit β) [9] kin-10 (T01G9.6b)
FGF2 RPL6 (Large ribosomal subunit L6) [36] rpl-6 (R151.3)
FGF2 RPS19 (40S ribosomal protein S19) [37] rps-19 (T05F1.3)
FGF2 CEP57 (Translokin, Centrosomal protein of 57 kDa, Proliferation-inducing 
protein 8, PIG8) [44]
-
FGF2 SMN1 (Survival motor neuron protein) [45, 46] smn-1 (C41G7.1)
FGF2 FGA/FGB/FGG (Fibrinogen, alpha/beta/gamma polypeptides) [12, 47] -
FGF2 FN1 (Fibstatin, fragment of fibronectin) [11] C56C10.4
FGF2 API5 (Apoptosis inhibitor 5, Fibroblast growth factor 2-interacting factor, 
FIF) [48]
-
FGF2 SF3A2 (Splicing factor 3A subunit 2) [10] F11A10.2
FGF2 PTX3 (Long pentraxin 3) [49] -
FGF2 PF4 (CXC chemokine platelet factor 4) [50] -
FGF1, FGF2, FGF3, FGF4 GLG1 (Golgi apparatus protein 1 precursor, Cysteine-rich fibroblast 
growth factor receptor, CFR-1) [6,7]
F14E5.2
FGF3 EBNA1BP2 (rRNA processing protein EBP2, Nucleolar Binding Protein, 
NoBP) [51]
C18A3.3
FGF11-14 MAPK8IP2 (Islet-brain-2, JNK MAP kinase scaffold protein 2) [52] jip-1 (F56D12.4)
EGL-17 LRP-1 (Low-density lipoprotein Receptor Related, F29D11.1) [8] lrp-1
EGL-17 LRP-2 (Low-density lipoprotein Receptor Related, T21E3.3) [8] lrp-2
EGL-17 DAB-1 (Drosophila disabled homolog, M110.5) [8] dab-1/dab-2
- No approved gene name
Table 4: Summary of interaction strengths
Interactors Y2H- screen Co-IP Coloc Deloc Class
RPS-16 ++ ++ + + I
FTT-1 ++ +++ - + I
FTT-2 ++ +++ - + I
KIN-10 ++ + + + I
PAL-1 +++ + + + I
C15C6.2 ++ ++ + - II
RPL-6 ++ ++ - + II
DAF-21 + ++ ND III
COL-129 ++ + + - III
SKR-2 ++ ++ ND III
KIN-3 + ++ +/- - III
C18A3.3 + ++ ND III
Scores obtained in the different assays used: (i) two-hybrid assays, (ii) co-immunoprecipitation (co-IP), (iii) colocalization by immunofluorescence in 
single transfected cells (Coloc) and (iv) delocalization (Deloc) of one or the two partners induced by the cotranfection. Interactions were classified 
as I (the strongest) to III (the weakest).
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involved in various aspects of protein synthesis or degra-
dation. Further analysis by co-immunoprecipitation and
colocalization confirmed the interactions identified. We
demonstrated that not only LET-756 could interact with
mammalian partners as well as their orthologs (e.g 14-3-
3β vs FTT-1/PAR-5 and FTT-2) but also that orthologs of
mammalian FGF partners could interact with LET-756
(CK2β vs KIN-10). Analyses of these partners could be of
interest in the study of mammalian FGFs.
The majority of the proteins we identified are nuclear,
which was expected since the two-hybrid system needs the
fusion to be targeted to the nucleus. However, some inter-
actions have been identified as false positive in other
screens [28]. By performing co-immunoprecipitations
and studying subcellular localization, we validated the
interaction of LET-756 with RPS-16, FTT-1/PAR-5, FTT-2,
KIN-10 and RPL-6 with high score, and with PAL-1, DAF-
21, SKR-2, KIN-3 and C18A3.3 with lower strength (see
Table 6). The function of some interacting partners is rel-
evant to FGF biology. The 14-3-3/FTT-1/FTT-2 proteins,
which belong to the highly conserved family of chaperone
molecules transit to the nucleus and participate in nucleo-
cytoplasmic transport, regulating intracellular transduc-
tion [30]. We did not find a 14-3-3 conventional phos-
phorylated binding site on LET-756. However, other
domains have been involved in 14-3-3 binding, such as
nuclear localization signals (31 for review). No role for
FTT-1 or FTT-2 in modulating secretion has been assigned
in C. elegans. It will be interesting to analyze whether
interaction of these proteins with the EFVSVA motif of
secretion described in LET-756 [16] causes its secretion.
The interaction of LET-756 with PAL-1 is of interest
because PAL-1 is also highly conserved during evolution.
It is the ortholog of caudal (Drosophila), CDX1, 2 and 4
(mammals) and Xcad3 (Xenopus) paraHOX proteins.
Caudal proteins are involved in the transcriptional regula-
tion of multiple genes that are involved in posterior pat-
terning [32]. The interaction of LET-756 with PAL-1 could
activate the expression of various genes involved in nem-
atode anterior-posterior development as it is the case for
the interaction of Xenopus e-FGF with Xcad3 and the
resulting activation of HOX genes [33,34]. In addition,
pal-1 mutant exhibits aberrant cell position in posterior
muscle cells [35], a site of LET-756 expression [13,19] as
well as in posterior hypodermis, a site of LET-756 action
[17]. Both muscle and epidermis evolve from the C line-
age. In the absence of PAL-1, the C blastomeres fail to
develop. Protein phosphorylation by the coordinated
activities of protein kinases and phosphatases is central to
many signal transduction pathways. The combined action
of LET-756/FGF, EGL-15 receptor, CLR-1 phosphatase
(for a review see [14]) and KIN-3 and KIN-10, the respec-
tive catalytic and regulatory subunits of CK2, might regu-
late various processes involved in proliferation -as it is
described for FGF1 and 2 [43,9] – or in other functions.
KIN-3 and KIN-10 have been recently implicated in pri-
mary cilia biology [55]. Finally, some ribosomal proteins
Co-immunoprecipitation of LET-756::GFP and HA-tagged protein partnersFigure 1
Co-immunoprecipitation of LET-756::GFP and HA-tagged protein partners Cos-1 cells were transfected with let-
756::gfp alone (0) and with various HA-tagged constructs presumed or not (TACC1) to interact with LET-756. Twenty four 
hours later cell lysates were immunoprecipitated with anti-GFP antibodies. Western blots were first revealed with anti-HA 
antibodies and then with anti-GFP antibodies. An additional band, indicated with an asterisk, was consistently observed with 
HA- tagged RPL-6. A week and non- reproducible band can also be seen in the FTT-2 co-immunoprecipitation lane. None of 
these bands arose from possible complexes since 1) electrophoresis was performed in denaturating conditions and 2) antibody 
detection relied on the tag epitope and not on the endogenous protein.
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interact with mammalian FGF [36-38] to regulate their
signaling and trafficking to the nucleus; reciprocally, FGFs
may regulate ribosome biogenesis and protein synthesis
during the G1 phase of the cell cycle. In contrast to these
relevant interactors, others appear irrelevant, such as
MBD1 since no methylation occurs in C. elegans.
The interactions revealed by the two-hybrid screens are
rather weak. This could be due to 1) the high stringency
associated with the system using the MAV 103/203 yeast
strains; it is worth noting that in large-scale screenings of
interactions no partner for LET-756 was found [20]; 2) a
bad exposure of the binding site in the fusion proteins; 3)
the existence of ternary interactions as seen in the ligand
– tyrosine kinase receptor – heparan sulphate complex
and 4) the need for post-translational modifications of
the proteins that occur in mammalian cells and not in
yeast, explaining why better interactions between glyco-
sylated LET-756 [16] and various partners were obtained
in immunoprecipitation and immunofluorescence exper-
iments than in yeast two-hybrid screens.
Finally, it will be interesting to know whether the expres-
sion pattern of LET-756, which is mainly muscular and
neuronal in the worm, overlap with that of the various
partners. Search in the literature (56, 57) was not conclu-
sive since the majority of the partners were found in eggs
(FTT-1/PAR-5, FTT-2, DAF-21, PAL-1), intestine (HSP-6,
SKR-2) or cuticle (COL-129).
Conclusion
We have conducted the first extensive search for LET-756
interactors and established the first interaction map of
LET-756/FGF with FGF binding proteins (Fig. 3 and Table
6). This could help understand FGF functions. Proteins of
interest were involved in developmental processes or in
basic biochemical events such as ribosome biogenesis and
protein synthesis. In addition, to get insight in the evolu-
tion of the FGF interactome network, which we have illus-
trated in Fig. 3, we tested 6 of 20 orthologs of human FGF
interactors (Table 6), and found KIN-10 and RPL-6 as new
potential interactors. Looking for physical interactions in
Intracellular localization of LET-756::GFP and HA-tagged protein partnersFigur  2
Intracellular localization of LET-756::GFP and HA-tagged protein partners Cos-1 cells were transfected with let-
756::gfp with or without various HA-tagged encoded constructs. Twenty four hours later cells were either fixed in 4% parafor-
maldehyde and permeabilized in triton or in cold methanol. Cells were incubated for an hour with rat anti-HA antibodies. Sec-
ondary goat anti-rat Texas red-coupled antibodies were then added for another 30 min. Coverslips were visualized with a 
confocal Leica microscope. Cells were transfected with the HA-tagged protein alone (column I) or cotransfected with let-
756::gfp and revealed by direct fluorescence (column II), by anti-HA immunofluorescence (column III) and merge (column IV). 
In cells cotransfected with LET-756 and KIN-10 and treated with actinomycin D, both GFP staining and anti-HA immunostain-
ing are displaced around and into the nucleolus. The yellow star indicates a neighbor single KIN-10 transfected cells. Its locali-
zation is not modified by the drugs. Panels A and B each show results for five interactors analyzed.
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a physiological system will determine which of these
interactions are essential.
In conclusion, 1) combining the yeast two-hybrid screen
with bioinformatics and computational biology, we have
delineated potential interactors of LET-756, and possibly
of the entire FGF family; 2) comparative genomics analy-
sis yielded valuable insights into conserved and divergent
aspects of function, regulation, and evolution since not all
pathways are conserved as demonstrated by the ortholog
analysis; 3) the information given herein, although not
complete, might be useful for people working in the field.
Methods
Yeast two-hybrid assays
A full-length let-756 transcript was fused in-frame with the
coding sequence of the DNA binding domain (DB) of
Gal4, and was used in a Y2H screen system as described in
[20] for the C elegans libraries. Two worm libraries fused
to the activation domain (AD) of Gal4, a cDNA and the
AD-ORFeome libraries [53] were screened. The MAV103
yeast strain based Y2H assay contains three reporter genes
(HIS3, lacZ and URA3) [54]. A cDNA human placenta
library fused to the activation domain of LexA was also
screened. The L40 yeast strain based Y2H assay contains
only two reporters (HIS3 and lacZ). In this case, the full
length let-756 transcript was cloned into the LexA DNA
binding domain bait expression vector pBTM116B Kana.
Yeast assays were done using conventional lithium ace-
tate-based method. Clones were assigned scores for LacZ
expression, growth on plates lacking histidine but con-
taining 20 or 40 mM 3-amino triazol and in addition,
growth on plates lacking uracil for the C. elegans libraries.
To ascertain interactions, the gap repair technique was
performed as in [54].
Plasmid construction
To generate prey-tagged expression vectors used in co-
immunoprecipitation assay or immunofluorescence, the
coding regions of various genes were amplified by PCR
using as template the corresponding EST clones obtained
from RZPD (Berlin, Germany) and then inserted in the
expression vectors using Gateway technology (Invitrogen,
Carlsbad, CA).
Interactome of the FGF familyFigure 3
Interactome of the FGF family The identified interactors of various FGFs were grouped in six categories, depending of the 
functional activities of proteins. The human and C. elegans orthologs are indicated: human (white), worm (grey).
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LET-756::GFP was obtained as previously described [16].
Cell culture and in vivo interaction assay
Cos-1 cells grown in DMEM supplemented with 10% fetal
calf serum were plated in 60-mm dishes at a concentration
of 2 × 106 cells/dish and immediately transfected with 1µg
DNA in Fugene, according to the manufacturer instruc-
tions. Twenty four hours after transfection, cells were
lysed in 1 ml triton buffer (10 mM Tris, pH7.4, 100 mM
NaCl, 2.5 mM MgCl2, 1% triton, 1 mM EDTA, 10 mM
DTT). Detergent insoluble materials were removed by 30
min centrifugation at 13000 rpm at 4°C. Whole cell
lysates were first incubated with protein G-sepharose
beads and then with the relevant antibody for at least 2 hr.
Protein G-sepharose beads were then added for another
additional 2 hr and washed 3 times with lysis buffer.
Bound proteins were eluted by boiling in SDS sample
buffer and resolved on a 10% SDS-PAGE gel and analyzed
by Western blots. For immunofluorescence analysis, cells
grown on glass coverslips were fixed and permeabilized in
3.7% PAF and 0.1%Triton or in methanol for 6 min at -
20°C. Similar results were obtained using these different
modes of fixation. Cells were incubated with primary anti-
body for 1 hr and then incubated with Texas Red-conju-
gated secondary antibody for another hr. Plasmid LET-
756::GFP was visualized by autofluorescence. Coverslips
were examined using a Leica TCS NT confocal microscope.
The following antibodies were used: rat monoclonal anti-
HA (12CA5) antibody was from Roche (Indianopolis, IN,
USA), rabbit polyclonal anti-GFP from Abcam (Cam-
bridge, UK), Texas Red anti-rat antibody from Molecular
Probes (Eugene, OR, USA), peroxydase anti-mouse from
Santa Cruz (Santa Cruz, CA, USA)
Abbreviations
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bovine serum; DTT dithiotreitol; Y2H, yeast two hybrid;
GFP, green fluorescent protein
Authors' contributions
CP, YB and AH performed the two-hybrid screenings and
the analyses of the data, CP and FC the gap-repair confir-
mation of clones, FC and RR the co-immunoprecipitation
and immunofluorescence experiments, CP the art work.
CP played the major role in the bioinformatics analysis.
DB initiated the C. elegans project and helped draft the
manuscript. RR conceived and coordinated the study and
wrote the manuscript. All authors read and approved the
final manuscript.
Acknowledgements
We thank F. Birg and D. Maraninchi for encouragements, P. Pontarotti for 
helpful discussions, P. Lecine for advices during this study and J. Reboul for 
the gift of the ORFeome library and advices. The work has been supported 
by Inserm, Institut Paoli-Calmettes and grants from the Ligue Nationale 
Contre le Cancer (Label).
References
1. Goldfarb M: Functions of fibroblast growth factors in verte-
brate development.  Cytokine Growth Factor Rev 1996, 7:311-325.
2. Dickson C, Spencer-Dene B, Dillon C, Fantl V: Tyrosine kinase sig-
nalling in breast cancer: fibroblast growth factors and their
receptors.  Breast Cancer Res 2000, 2:191-196.
3. Goldfarb M: Signaling by fibroblast growth factors: the inside
story.  Sci STKE 2001, 106:PE37.
4. Kolpakova E, Wiedlocha A, Stenmark H, Klingenberg O, Falnes PO,
Olsnes S: Cloning of an intracellular protein that binds selec-
tively to mitogenic acidic fibroblast growth factor.  Biochem J
1998, 336:213-222.
5. LaVallee TM, Tarantini F, Gamble S, Mouta Carreira C, Jackson A,
Maciag T: Synaptotagmin-1 is required for fibroblast growth
factor-1 release.  J Biol Chem 1998, 273:22217-22223.
6. Burrus LW, Zuber ME, Lueddecke BA, Olwin BB: Identification of
a cysteine-rich receptor for fibroblast growth factors.  Mol Cell
Biol 1992, 12:5600-5609.
7. Kohl R, Antoine M, Olwin BB, Dickson C, Kiefer P: Cysteine-rich
fibroblast growth factor receptor alters secretion and intra-
cellular routing of fibroblast growth factor 3.  J Biol Chem 2000,
275:15741-15748.
8. Kamikura DM, Cooper JA: Lipoprotein receptors and a disabled
family cytoplasmic adaptor protein regulate EGL-17/FGF
export in C. elegans.  Genes Dev 2003, 17:2798-2811.
9. Bonnet H, Filhol O, Truchet I, Brethenou P, Cochet C, Amalric F,
Bouche G: Fibroblast growth factor-2 binds to the regulatory
beta subunit of CK2 and directly stimulates CK2 activity
toward nucleolin.  J Biol Chem 1996, 271:24781-24787.
10. Gringel S, van Bergeijk J, Haastert K, Grothe C, Claus P: Nuclear
fibroblast growth factor-2 interacts specifically with splicing
factor SF3a66.  Biol Chem 2004, 385:1203-1208.
11. Bossard C, Van den Berghe L, Laurell H, Castano C, Cerutti M, Prats
AC, Prats H: Antiangiogenic properties of fibstatin, an extra-
cellular FGF-2-binding polypeptide.  Cancer Res 2004,
64:7507-7512.
12. Peng H, Sahni A, Fay P, Bellum S, Prudovsky I, Maciag T, Francis CW:
Identification of a binding site on human FGF-2 for fibrino-
gen.  Blood 2004, 103:2114-2120.
13. Birnbaum D, Popovici C, Roubin R: A pair as a minimum: The
two fibroblast growth factors of the nematode Caenorhabdi-
tis elegans.  Dev Dyn 2005, 232:247-255.
14. Huang P, Stern MJ: FGF signaling in flies and worms: more and
more relevant to vertebrate biology.  Cytokine Growth Factor Rev
2005, 16:151-158.
15. Roubin R, Naert K, Popovici C, Vatcher G, Coulier F, Thierry-Mieg J,
Pontarotti P, Birnbaum D, Baillie D, Thierry-Mieg D: let-756, a C.
elegans fgf essential for worm development.  Oncogene 1999,
18:6741-6747.
16. Popovici C, Conchonaud F, Birnbaum D, Roubin R: Functional phy-
logeny relates LET-756 to FGF9.  J Biol Chem 2004,
279:40146-40152.
17. Huang P, Stern MJ: FGF signaling functions in the hypodermis
to regulate fluid balance in C. elegans.  Development 2004,
131:2595-2604.
18. Bulow HE, Boulin T, Hobert O: Differential functions of the C.
elegans FGF receptor in axon outgrowth and maintenance of
axon position.  Neuron 2004, 42:367-374.
19. Popovici C, Fallet M, Marguet D, Birnbaum D, Roubin R: Intracellu-
lar trafficking of LET-756, a fibroblast growth factor of C. ele-
gans, is controlled by a balance of export and nuclear signals.
Exp Cell Res 2006, 312:1484-1495.
20. Reboul J, Vaglio P, Rual JF, Lamesch P, Martinez M, Armstrong CM, Li
S, Jacotot L, Bertin N, Janky R, Moore T, Hudson JR Jr, Hartley JL, Bra-
sch MA, Vandenhaute J, Boulton S, Endress GA, Jenna S, Chevet E,
Papasotiropoulos V, Tolias PP, Ptacek J, Snyder M, Huang R, Chance
MR, Lee H, Doucette-Stamm L, Hill DE, Vidal M: C. elegans ORFe-
ome version 1.1: experimental verification of the genome
annotation and resource for proteome-scale protein expres-
sion.  Nat Genet 2003, 34:35-41.
21. Baugh LR, Hill AA, Claggett JM, Hill-Harfe K, Wen JC, Slonim DK,
Brown EL, Hunter CP: The homeodomain protein PAL-1 spec-
Publish with BioMed Central   and  every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
BMC Genomics 2006, 7:105 http://www.biomedcentral.com/1471-2164/7/105
Page 10 of 10
(page number not for citation purposes)
ifies a lineage-specific regulatory network in the C. elegans
embryo.  Development 2005, 132:1843-1854.
22. Birnby DA, Link EM, Vowels JJ, Tian H, Colacurcio PL, Thomas JHA:
Transmembrane guanylyl cyclase (DAF-11) and Hsp90
(DAF-21) regulate a common set of chemosensory behav-
iors in Caenorhabditis elegans.  Genetics 2000, 155:85-104.
23. Inoue T, Takamura K, Yamae H, Ise N, Kawakami M, Tabuse Y, Miwa
J, Yamaguchi Y: Caenorhabditis elegans DAF-21 (HSP90) is
characteristically and predominantly expressed in germline
cells: spatial and temporal analysis.  Dev Growth Differ 2003,
45:369-376.
24. Nayak S, Santiago FE, Jin H, Lin D, Schedl T, Kipreos ET: The
Caenorhabditis elegans Skp1-related gene family: diverse
functions in cell proliferation, morphogenesis, and meiosis.
Curr Biol 2002, 12:277-287.
25. Yamanaka A, Yada M, Imaki H, Koga M, Ohshima Y, Nakayama K:
Multiple Skp1-related proteins in Caenorhabditis elegans :
diverse patterns of interaction with Cullins and F-box pro-
teins.  Curr Biol 2002, 12:267-275.
26. Popovici C, Roubin R, Coulier F, Birnbaum D: An evolutionary his-
tory of the FGF superfamily.  Bioessays 2005, 27:849-857.
27. Itoh N, Ornitz DM: Evolution of the Fgf and Fgfr gene families.
Trends Genet 2004, 20:563-569.
28. Van Criekinge W, Beyaert R: Yeast Two-Hybrid: State of the
Art.  Biol Proced Online 1999, 2:1-38.
29. Burdine RD, Chen EB, Kwok SF, Stern MJ: egl-17 encodes an inver-
tebrate fibroblast growth factor family member required
specifically for sex myoblast migration in Caenorhabditis ele-
gans.  Proc Natl Acad Sci USA 1997, 94:2433-2437.
30. Aitken A: 14-3-3 and its possible role in co-ordinating multiple
signalling pathways.  Trends Cell Biol 1996, 6:341-347.
31. Bridges D, Moorhead GB: 14-3-3 proteins: a number of func-
tions for a numbered protein.  Sci STKE 2005, 296:re10.
32. Pellettieri J, Seydoux G: Anterior-posterior polarity in C. ele-
gans and Drosophila – PARallels and differences.  Science 2002,
298:1946-1950.
33. Pownall ME, Tucker AS, Slack JM, Isaacs HV: eFGF, Xcad3 and Hox
genes form a molecular pathway that establishes the anter-
oposterior axis in Xenopus.  Development 1996, 122:3881-3892.
34. Isaacs HV, Pownall ME, Slack JM: Regulation of Hox gene expres-
sion and posterior development by the Xenopus caudal
homologue Xcad3.  EMBO J 1998, 17:3413-3427.
35. Edgar LG, Carr S, Wang H, Wood WB: Zygotic expression of the
caudal homolog pal-1 is required for posterior patterning in
Caenorhabditis elegans embryogenesis.  Dev Biol 2001,
229:71-88.
36. Shen B, Arese M, Gualandris A, Rifkin DB: Intracellular association
of FGF-2 with the ribosomal protein L6/TAXREB107.  Bio-
chem Biophys Res Commun 1998, 252:524-528.
37. Soulet F, Al Saati T, Roga S, Amalric F, Bouche G: Fibroblast growth
factor-2 interacts with free ribosomal protein S19.  Biochem
Biophys Res Commun 2001, 289:591-596.
38. Skjerpen CS, Wesche J, Olsnes S: Identification of ribosome-
binding protein p34 as an intracellular protein that binds
acidic fibroblast growth factor.  J Biol Chem 2002,
277:23864-23871.
39. Mizukoshi E, Suzuki M, Loupatov A, Uruno T, Hayashi H, Misono T,
Kaul SC, Wadhwa R, Imamura T: Fibroblast growth factor-1
interacts with glucose-regulated protein GRP75/mortalin.
Biochem J 1999, 343:461-466.
40. Ananyeva N, Tjurmin A, Saenko E, Haudenschild C: Low density
lipoproteins interact with acidic fibroblast growth factor and
modify its function.  Arterioscler Thromb Vasc Biol 2003, 23:601-607.
41. Carreira CM, LaVallee TM, Tarantini F, Jackson A, Lathrop JT, Hamp-
ton B, Burgess WH, Maciag T: S100A13 Is Involved in the Regu-
lation of Fibroblast Growth Factor-1 and p40
Synaptotagmin-1 Release in Vitro.  J Biol Chem 1998,
273:22224-22231.
42. Tassi E, Al-Attar A, Aigner A, Swift MR, McDonnell K, Karavanov A,
Wellstein A: Enhancement of fibroblast growth factor (FGF)
activity by an FGF-binding protein.  J Biol Chem 2001,
276:40247-40253.
43. Wiedlocha A, Falnes PO, Madshus IH, Sandvig K, Olsnes S: Dual
mode of signal transduction by externally added acidic
fibroblast growth factor.  Cell 1994, 76:1039-1051.
44. Bossard C, Laurell H, Van den Berghe L, Meunier S, Zanibellato C,
Prats H: Translokin is an intracellular mediator of FGF-2 traf-
ficking.  Nat Cell Biol 2003, 5:433-439.
45. Claus P, Doring F, Gringel S, Muller-Ostermeyer F, Fuhlrott J, Kraft
T, Grothe C: Differential intranuclear localization of fibroblast
growth factor-2 isoforms and specific interaction with the
survival of motoneuron protein.  J Biol Chem 2003, 278:479-485.
46. Claus P, Bruns AF, Grothe C: Fibroblast growth factor-2(23)
binds directly to the survival of motoneuron protein and is
associated with small nuclear RNAs.  BiochemJ 2004,
384:559-565.
47. Sahni A, Khorana AA, Baggs RB, Peng H, Francis CW: FGF-2 bind-
ing to fibrin(ogen) is required for augmented angiogenesis.
Blood 2006, 107:126-131.
48. Van den Berghe L, Laurell H, Huez I, Zanibellato C, Prats H, Bugler B:
FIF [fibroblast growth factor-2 (FGF-2)-interacting-factor],
a nuclear putatively antiapoptotic factor, interacts specifi-
cally with FGF-2.  Mol Endocrinol 2000, 14:1709-1724.
49. Camozzi M, Zacchigna S, Rusnati M, Coltrini D, Ramirez-Correa G,
Bottazzi B, Mantovani A, Giacca M, Presta M: Pentraxin 3 inhibits
fibroblast growth factor 2-dependent activation of smooth
muscle cells in vitro and neointima formation in vivo.  Arterio-
scler Thromb Vasc Biol 2005, 25:1837-1842.
50. Chadderton NS, Stringer SE: Interaction of platelet factor 4 with
fibroblast growth factor 2 is stabilised by heparan sulphate.
Int J Biochem Cell Biol 2003, 35:1052-1055.
51. Reimers K, Antoine M, Zapatka M, Blecken V, Dickson C, Kiefer P:
NoBP, a nuclear fibroblast growth factor 3 binding protein,
is cell cycle regulated and promotes cell growth.  Mol Cell Biol
2001, 21:4996-5007.
52. Schoorlemmer J, Goldfarb M: Fibroblast growth factor homolo-
gous factors and the islet brain-2 scaffold protein regulate
activation of a stress-activated protein kinase.  J Biol Chem
2002, 277:49111-49119.
53. Vaglio P, Lamesch P, Reboul J, Rual JF, Martinez M, Hill D, Vidal M:
The Caenorhabditis elegans ORFeome Database.  Nucleic Acids
Res 2003, 1:31237-31240.
54. Walhout AJ, Vidal M: High-throughput yeast two-hybrid assays
for large-scale protein interaction mapping.  Methods 2001,
24:297-306.
55. Hu J, Bae YK, Knobel KM, Barr MM: Casein Kinase II and Cal-
cineurin Modulate TRPP Function and Ciliary Localization.
Mol Biol Cell 2006, 17:2200-2211.
56.  [http://nematode.lab.nig.ac.jp/db2/].
57.  [http://elegans.bcgsc.ca/perl/eprofile/index].
58.  [http://www.wormbase.org].
